Chloroquine Related Compound A
USP/1118328 - United States Pharmacopeia (USP) Reference Standard
Synonym: 4,7-
CAS Number: 86-98-6
Empirical Formula (Hill Notation): C9H5Cl2N
Molecular Weight: 198.05
MDL Number: MFCD00006774
Linear Formula: C9H5Cl2N
Product Type: Chemical
agency | USP |
API family | chloroquine |
application(s) | pharmaceutical (small molecule) |
biological source | synthetic |
bp | 298.4 °F (148°C) |
color | off-white to brown-yellowish |
form | crystalline |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C9H5Cl2N/c10-6-1-2-7-8 |
InChI key | HXEWMTXDBOQQKO-UHFFFAOYSA |
manufacturer/tradename | USP |
mp | 81-83 °C (lit.) |
packaging | pkg of 15 mg |
pkg of 25 mg | |
SMILES string | Clc1ccc2c(Cl)ccnc2c1 |
solubility | ethanol: freely soluble |
ether: freely soluble | |
water: slightly soluble | |
storage temp. | 2-30°C |
vapor pressure | 0.0000811 kPa ( 25 °C) |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Chloroquine Related Compound A can be used as a pharmaceutical primary standard for the determination of the analyte in pharmaceutical formulations by liquid chromatography (LC) technique. |
General description: | Chloroquine Related Compound A is an impurity of chloroquine, which is a 9-aminoquinoline drug that effectively inhibits viral infections in humans. |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS07,GHS09 |
Signal word | Warning |
Hazard statements | H315 - H317 - H319 - H411 |
Precautionary statements | P261 - P264 - P273 - P280 - P302 + P352 - P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
bp | 298.4 °F (148°C) |
mp | 81-83 °C (lit.) |
Storage Temp. | 2-30°C |
UNSPSC | 41116107 |